SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-125438
Filing Date
2016-09-27
Accepted
2016-09-27 10:50:31
Documents
2
Period of Report
2016-09-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v449498_8k.htm 8-K 18363
2 EXHIBIT 99.1 v449498_ex99-1.htm EX-99.1 8112
  Complete submission text file 0001144204-16-125438.txt   27678
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-191083 | Film No.: 161903630
SIC: 2834 Pharmaceutical Preparations